BDBM645365 Synthesis of (1R,3R)-3-[(7S)-2-[(R)-(5-fluoro-2-methoxyphenyl)(hydroxy)methyl]-6-(methoxycarbonyl)-7-methyl-3H,6H,7H,8H,9H-imidazo[4,5-f]quinolin-3-yl]cyclohexane-1-carboxylic acid ::US20240016795, Compound 1

SMILES COC(=O)N1[C@@H](C)CCc2c1ccc1n([C@@H]3CCC[C@H](C3)C(O)=O)c(nc21)[C@H](O)c1cc(F)ccc1OC

InChI Key InChIKey=NOUKMOKAEKAWKS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 645365   

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM645365(US20240016795, Compound 1 | Synthesis of (1R,3R)-3...)
Affinity DataIC50: 10nMAssay Description:The potency and selectivity of CBP/P300 inhibitor compounds including Compound 1 were determined in biochemical time resolved fluorescence assays usi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
US Patent